Literature DB >> 26713666

A pilot single-centre randomized trial assessing the safety and efficacy of lateral pararectus abdominis compared with transrectus abdominis muscle stoma placement in patients with temporary loop ileostomies: the PATRASTOM trial.

J Hardt1, S Seyfried1, C Weiß2, S Post1, P Kienle1, F Herrle1.   

Abstract

AIM: Transrectal stoma placement is considered the standard technique for positioning a stoma. A prospective series using a novel method of lateral pararectal stoma placement recently revealed a remarkably low stoma herniation rate. A randomized trial was conducted to compare the lateral pararectal with the transrectal stoma position with regard to parastomal herniation, stoma-related morbidity and quality of life.
METHOD: Adult patients undergoing elective placement of a temporary loop ileostomy were eligible for inclusion. Patients were intra-operatively randomized to undergo either a lateral pararectal or a transrectal ileostomy. The primary end-point was the rate of parastomal herniation. Secondary end-points included other stoma-related complications and quality of life. Sample size calculation resulted in 54 patients having to be analysed to detect a difference of parastomal herniation of 30% with an 80% power and a 5% significance level. The trial was registered with the German Clinical Trials Register (registration number DRKS00003534).
RESULTS: Between April 2012 and April 2014, 30 patients were randomized to each group. The incidence of parastomal herniation did not differ between the lateral pararectal (5 of 27) and the transrectal group (4 of 29; P = 0.725). There was also no significant difference regarding other stoma-related complications and the EORTC quality of life scales C30 and CR29.
CONCLUSION: The incidence of parastomal herniation and other stoma-related complications did not differ between the groups. However, due to the limited sample size a small difference in favour of one of the two stoma placement techniques cannot be entirely ruled out. Colorectal Disease
© 2015 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Parastomal hernia; prevention; randomized controlled trial

Mesh:

Year:  2016        PMID: 26713666     DOI: 10.1111/codi.13251

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

Review 1.  The incidence of stoma related morbidity - a systematic review of randomised controlled trials.

Authors:  Tam Malik; M J Lee; A B Harikrishnan
Journal:  Ann R Coll Surg Engl       Date:  2018-08-16       Impact factor: 1.891

Review 2.  European Hernia Society guidelines on prevention and treatment of parastomal hernias.

Authors:  S A Antoniou; F Agresta; J M Garcia Alamino; D Berger; F Berrevoet; H-T Brandsma; K Bury; J Conze; D Cuccurullo; U A Dietz; R H Fortelny; C Frei-Lanter; B Hansson; F Helgstrand; A Hotouras; A Jänes; L F Kroese; J R Lambrecht; I Kyle-Leinhase; M López-Cano; L Maggiori; V Mandalà; M Miserez; A Montgomery; S Morales-Conde; M Prudhomme; T Rautio; N Smart; M Śmietański; M Szczepkowski; C Stabilini; F E Muysoms
Journal:  Hernia       Date:  2017-11-13       Impact factor: 4.739

Review 3.  Italian guidelines for the surgical management of enteral stomas in adults.

Authors:  F Ferrara; D Parini; A Bondurri; M Veltri; M Barbierato; F Pata; F Cattaneo; A Tafuri; C Forni; G Roveron; G Rizzo
Journal:  Tech Coloproctol       Date:  2019-10-12       Impact factor: 3.781

4.  Lateral pararectal versus transrectal stoma placement for prevention of parastomal herniation.

Authors:  Julia Hardt; Joerg J Meerpohl; Maria-Inti Metzendorf; Peter Kienle; Stefan Post; Florian Herrle
Journal:  Cochrane Database Syst Rev       Date:  2019-04-24

5.  What should be included in case report forms? Development and application of novel methods to inform surgical study design: a mixed methods case study in parastomal hernia prevention.

Authors:  Charlotte Murkin; Leila Rooshenas; Neil Smart; I R Daniels; Tom Pinkney; Jamshed Shabbir; Timothy Rockall; Joanne Bennett; Jared Torkington; Jonathan Randall; H T Brandsma; Barnaby Reeves; Jane Blazeby; Natalie S Blencowe
Journal:  BMJ Open       Date:  2022-10-05       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.